BioNexus Gene Lab
BGLC
$0.61
Share price
5.03%
Change (1 day)
144.52%
Change (1 year)
Categories
BioNexus Gene Lab (BGLC) - Total debt
Total debt on the balance sheet as of December 2023 : $0.13 M
According to BioNexus Gene Lab's latest financial reports the company's total debt is $0.13 M. A company’s total debt is the sum of all current and non-current debts.
BioNexus Gene Lab - Total debt on balance sheet (from 2019 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.05 M | -26.22% |
| 2021-12-31 | $0.07 M | -37.65% |
| 2020-12-31 | $0.12 M | 38% |
| 2019-12-31 | $0.08 M | 8.98% |
| 2018-12-31 | $0.08 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.75 M | 1,963.05% | 🇺🇸 USA |